期刊文献+

人内皮抑素基因改造、表达、纯化及活性检测 被引量:1

Gene Modification, Expression and Purification of Human Endostatin and Its Biological Activity
原文传递
导出
摘要 目的克隆诱变的人内皮抑素(human endostatin,hES)氨基端基因,并检测其活性。方法双酶切已诱变的人内皮抑素基因,电泳回收氨基端片段,与质粒pTYB-2重组,转化E.coli BL-21(DE3)。通过鸡胚绒毛尿囊膜(CAM)实验,MTT实验,HE染色及流式细胞术检测重组小分子人内皮抑素对新生血管生成、细胞增殖和细胞凋亡的影响。结果基因重组小分子内皮抑素对鸡胚尿囊膜新生血管生成具有明显的抑制作用;对脐静脉内皮细胞和肝癌细胞增殖的抑制存在量效关系;作用24h后,观察到细胞凋亡现象;与对照组相比,细胞凋亡数增加。结论成功构建了人内皮抑素氨基端基因工程菌,得到了具有生物活性的氨基端小分子内皮抑素,为便利临床应用奠定了基础。 Objective To clone the N-terminal sequence of mutant-type human endostatin and investigate its biological activities. Methods The mutant-type human endostatin gene was digested by two restriction endonucleases and the N-terminal gene fragment was recovered by electrophoresis. Then the fragment was cloned into the E. coli expressing plasmid pTYB-2, transformed into E. coli strain BI21 (DE3) and expressed by IPTG induction. After purification by one-step affinity chromatography, the small endostatin protein was obtained and its activity was analyzed by chick embryo chorioallantoic membrane (CAM). The effect of the small endostatin on cell lines was examined by using MTF assay. The morphological change of cells was observed by HE staining. The apoptosis of cells was detected by the flow cytometry. Results The angiogenesis of CAM was inhibited by the small endostatin protein. MTr assay showed that the inhibition was obviously enhanced as the concentration increased. Morphological observation showed that apoptosis happened after the cells were treated with the protein for 24 hours and the small endostatin increased the apoptotic cell. Conclusion The recombinant N-terminal sequence of mutant-type human endostatin was transformed into the host stain E. Coli and the N-terminal small protein has biological activity.
出处 《医学分子生物学杂志》 CAS CSCD 2005年第6期409-412,共4页 Journal of Medical Molecular Biology
基金 国家自然科学基金(No.30400063)
关键词 人内皮抑素 基因改造 DNA重组 human endostatin, gene modification, DNA cloning
  • 相关文献

参考文献11

  • 1O' Reilly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth.Cell, 1997, 88 (2): 277-85.
  • 2任明华,王淑静,林雪松,徐建永,陶站华,赵炜明,刘兴汉.重组人内皮抑素的结构改造及抗肿瘤活性变化[J].中国生物化学与分子生物学报,2005,21(1):45-52. 被引量:17
  • 3任明华,刘兴汉,闫玉清,姚鸿超,王淑晶,徐建勇.重组人内皮抑素的表达、纯化、复性方法研究[J].中国肿瘤,2003,12(10):598-601. 被引量:5
  • 4余琼,周凌云,林雪松,徐建永,王淑静,刘兴汉.重组人成骨生长肽的表达、纯化和活性的研究[J].中国生物化学与分子生物学报,2004,20(4):467-472. 被引量:14
  • 5刘秀萍,王淑静,刘兴汉.用鸡胚尿囊膜血管检测内皮抑素活性方法的建立[J].哈尔滨医科大学学报,2002,36(1):73-73. 被引量:3
  • 6Boehm T, Folkman J, Browder T, et al. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature, 1997, 390 (6 658): 404-7.
  • 7Black WR, Agner RC. Tumour regression after endostatin therapy. Nature, 1998, 391 (6 666): 450.
  • 8Sasaki T, Larsson H, Kreuger J, et al. Structure basis and potential role of heparin/heparin sulfate binding to the angiogenesis inhibitor endostatin. EMBO J, 1999, 18:6 240-8.
  • 9Ricard-Blum S, Ferand O, Lortat-Jacob H, et al. Characterization of endostatin binding to heparin and heparan sulfate by surface plasmon resonance and molecular modeling:role of divalent cations. J Biol Chem, 2004,279(4) :2 927-36.
  • 10Hohenester E, Sasaki T, Olsen BR, et al. Crystal structure of the angiogenesis inhibitor endostatin at 1.5 A resolution. EMBO J, 1998, 17 (6): 1 656-64.

二级参考文献16

  • 1Bab I, Gazit D, Chorev M, Muhlrad A, Shteyer A, Greenberg Z,Namdar M, Kahn A. HistoneH4-related osteogenic growth peptide (OGP): a novel circulating stimulator of osteoblastic activity. EMBO J, 1992,11(5): 1867 ~ 1873
  • 2Bab I A, Einhorn T A. Polypeptide factors regulating osteogensis and bone marrow repair. J Cell Biochem. 1994, 55(3) :358 - 365
  • 3Greenberg Z, Chorev M, Muhlrad A, Shteyer A, Namdar M, Mansur N, Bab I. Mitogenic action of osteogenic growth peptide(OGP): role of amino and carboxy-terminal regions and charge. Biochim Biophys Acta,1993,1178:273 ~ 280
  • 4Bakalkin G Y, Rakhmaniova A B, Akparow V K, Volodin A A,Ovchinnikov V V, Sarkisyam R A. Amino acid sequence pattern in the regulatory peptides. Int J Pept Protein Res, 1991,38 ( 6 ): 505 - 510
  • 5Perler F B, Davis G E, Deam G E, Gimble F S, Jack W E, Neff N, Noren C J, Thorner J, Belfort M. Protein splicing elements: inteins and exteinsa definition of terms and recommended nomenclature. Nucleic Acids Res,1994,22(7):125~127
  • 6Greenberg Z, Gavish H, Muhlrad A, Chorev M, Shteyer A, AttarNamdar M, Tartakovsky A, Bab I. Isolation of osteogenic growth peptide from osteoblastic MC3T3 El cell culutures anddemonstration of OGP binding proteins. J Cell Biochem, 1997,65:359 ~ 367
  • 7Gavish H, Bab I, Tartakovsky A, Chorev M, Mansur N, Greenberg Z,Nandar- Attar M. Humanalpha2-macroglobulin is an Osteogenic growth peptide-binding protein. Biochemistry, 1997,36:14883 - 14888
  • 8Bab I, Gavish H, Namdar-Attar M, Muhirad A, Greenberg Z, Chen Y, Mansur N, ShteyerA, Chorev M. Isolation of mitogenically active C terminal truncated pentapeptide of osteogenic growth peptide from human plasma and culture medium of murine osteoblastic cel
  • 9Gurevitch O, Slavin S, Muhlrad A, Shteyer A, Gazit D, Chorev M,Vidson M, Namdar- Attar M,Berger E, Bleiberg I, Bab. Osteogenic growth peptide increase blood and bone marrow cellularity and enhances engraftment of bone marrow transplants in mice. Blood, 19
  • 10Chong S, Mersha F B, Comb D G, Scott M E, Landry D, Vence L M,Perler FB, Benner J, Kucera RB, Hirvonen CA , Pelletier JJ, Paulus H, Xu MQ. Single-column purification of free recombinant proteins using a self-cleavable affinity tag derived from a protein s

共引文献35

同被引文献7

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部